0.31Open0.31Pre Close0 Volume43 Open Interest65.00Strike Price0.00Turnover349.54%IV17.17%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.31Extrinsic Value100Contract SizeAmericanOptions Type-0.0671Delta0.0130Gamma251.94Leverage Ratio-1.2875Theta-0.0001Rho-16.90Eff Leverage0.0037Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet